Association between First Nations ethnicity and progression to kidney failure by presence and severity of albuminuria

CMAJ. Canadian Medical Association Journal

Volumn 186, Issue 2, 2014, Pages

  Samuel, Susan M ^a   Palacios Derflingher, Luz ^a   Tonelli, Marcello ^a   Manns, Braden ^a   Crowshoe, Lynden ^a   Ahmed, Sofia B ^a   Jun, Min ^a   Saad, Nathalie ^a   Hemmelgarn, Brenda R ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALBUMINURIA; ARTICLE; CANADA; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMORBIDITY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; ETHNICITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION BASED CASE CONTROL STUDY; POPULATION RISK; RENAL REPLACEMENT THERAPY;

ADULT; ALBERTA; ALBUMINURIA; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; INDIANS, NORTH AMERICAN; MALE; MIDDLE AGED; RENAL INSUFFICIENCY; RISK FACTORS;

EID: 84894170158     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.130776     Document Type: Article

References (29)

1. Gao S, Manns BJ, Culleton BF, et al. Prevalence of chronic kidney disease and survival among aboriginal people. J Am Soc Nephrol 2007;18: 2953-9.
2. Dyck RF. Mechanisms of renal disease in indigenous populations: influences at work in Canadian indigenous peoples. Nephrology (Carlton) 2001;6: 3-7.
3. Young TK, Reading J, Elias B, et al. Type 2 diabetes mellitus in Canada's First Nations: status of an epidemic in progress. CMAJ 2000; 163: 561-6.
4. Samuel SM, Foster BJ, Hemmelgarn BR, et al. Incidence and causes of end-stage renal disease among Aboriginal children and young adults. CMAJ 2012;184:E758-64.
5. Dyck RF, Tan L. Non-diabetic end-stage renal disease among Saskatchewan Aboriginal people. Clin Invest Med 1998;21: 33-8.
6. Gansevoort RT, Matsushita K, van der Velde M, et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 2011;80: 93-104.
7. McClellan W, Warnock DG, McClure L, et al. Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study. J Am Soc Nephrol 2006;17: 1710-5.
8. Pavkov ME, Knowler WC, Bennett PH, et al. Increasing incidence of proteinuria and declining incidence of end-stage renal disease in diabetic Pima Indians. Kidney Int 2006;70: 1840-6.
9. Hoy WE, Wang Z, VanBuynder P, et al. The natural history of renal disease in Australian Aborigines. Part 2. Albuminuria predicts natural death and renal failure. Kidney Int 2001;60: 249-56.
10. Hemmelgarn BR, Clement F, Manns BJ, et al. Overview of the Alberta Kidney Disease Network. BMC Nephrol 2009;10:30.
11. Population by selected ethnic origins, by province or territory (2006 census). Ottawa (ON): Statistics Canada; 2006.
12. Aboriginal peoples of Canada: highlight tables, 2001 census. Ottawa (ON): Statistics Canada; 2001. Cat. no. 97F0024XIE 2001007.
13. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-12.
14. Hemmelgarn BR, Manns BJ, Lloyd A, et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA 2010; 303: 423-9.
15. Lamb EJ, MacKenzie F, Stevens PE. How should proteinuria be detected and measured? Ann Clin Biochem 2009;46: 205-17.
16. Southern DA, McLaren L, Hawe P, et al. Individual-level and neighborhood-level income measures: agreement and association with outcomes in a cardiac disease cohort. Med Care 2005; 43: 1116-22.
17. Hux JE, Ivis F, Flintoft V, et al. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002;25: 512-6.
18. Quan H, Khan N, Hemmelgarn BR, et al. Validation of a case definition to define hypertension using administrative data. Hypertension 2009;54: 1423-8.
19. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43: 1130-9.
20. Lambers Heerspink HJ, Perkovic V., de Zeeuw D. Is doubling of serum creatinine a valid clinical 'hard' endpoint in clinical nephrology trials? Nephron Clin Pract 2011;119:c195-99.
21. Grambsch P, Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994;81: 515-26.
22. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94: 496-509.
23. Dyck RF, Tan L. Rates and outcomes of diabetic end-stage renal disease among registered native people in Saskatchewan. CMAJ 1994; 150: 203-8.
24. Dyck RF, Hayward MN, Harris SB. Prevalence, determinants and co-morbidities of chronic kidney disease among First Nations adults with diabetes: results from the CIRCLE study. BMC Nephrol 2012;13:57.
25. Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with allcause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375: 2073-81.
26. Shah BR, Gunraj N, Hux JE. Markers of access to and quality of primary care for aboriginal people in Ontario, Canada. Am J Public Health 2003;93: 798-802.
27. Gao S, Manns BJ, Culleton BF, et al. Access to health care among status Aboriginal people with chronic kidney disease. CMAJ 2008;179: 1007-12.
28. Jetté N, Quan H, Faris P, et al. Health resource use in epilepsy: significant disparities by age, gender, and Aboriginal status. Epilepsia 2008;49: 586-93.
29. Hall YN, O'Hare AM, Young BA, et al. Neighborhood poverty and kidney transplantation among US Asians and Pacific Islanders with end-stage renal disease. Am J Transplant 2008; 8: 2402-9.